文献速递肝病

无创工具序贯联合提高NAFLD患者严重肝纤维化诊断准确性

Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.
PubMed 文献 · Aliment Pharmacol Ther · 2017-07-27

该研究基于741例经组织学诊断的NAFLD患者,评估无创工具配对或序贯联合诊断严重纤维化的性能。LSM、NFS和FIB-4是分期F3-F4纤维化的最佳无创工具,AUC分别为0.863、0.774和0.792。LSM与FIB-4/NFS序贯联合诊断准确性在69.8%至70.1%之间,不确定区域为18.9%至20.4%。

要点

  • LSM诊断F3-F4纤维化AUC为0.863,灵敏度90%,阴性预测值94%。
  • NFS和FIB-4特异度分别为97%和93%,阳性预测值分别为73%和79%。
  • LSM与FIB-4/NFS序贯联合诊断准确性为69.8%至70.1%。

核心结论

  • LSM与FIB-4/NFS序贯联合对NAFLD严重纤维化的无创诊断具有良好诊断准确性。

研究设计与样本

  • 分析741例经组织学诊断为NAFLD的患者数据,计算GGT/PLT、APRI、AST/ALT、BARD、FIB-4和NAFLD纤维化评分(NFS),并通过FibroScan进行肝脏硬度测量(LSM)。

主要发现

  • LSM、NFS和FIB-4是分期F3-F4纤维化的最佳无创工具,AUC分别为0.863、0.774和0.792。
  • LSM灵敏度最高为90%,阴性预测值最高为94%;NFS和FIB-4特异度最高分别为97%和93%,阳性预测值最高分别为73%和79%。
  • LSM或NFS与FIB-4配对联合使错误分类患者可能性降至2.7%至2.6%,但不确定区域高达54.1%至58.2%,总体准确性低至43%至39.1%。
  • 序贯联合(第一项检测灰区及高LSM值(>9.6 KPa)或低NFS或FIB-4值(分别<-1.455和<1.30)者使用第二项检测)总体提高诊断性能,准确性为69.8%至70.1%,不确定区域为18.9%至20.4%,错误分类率为9.2%至11.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The accuracy of available non-invasive tools for staging severe fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) is still limited. AIM: To assess the diagnostic performance of paired or serial combination of non-invasive tools in NAFLD patients. METHODS: We analysed data from 741 patients with a histological diagnosis of NAFLD. The GGT/PLT, APRI, AST/ALT, BARD, FIB-4, and NAFLD Fibrosis Score (NFS) scores were calculated according to published algorithms. Liver stiffness measurement (LSM) was performed by FibroScan. RESULTS: LSM, NFS and FIB-4 were the best non-invasive tools for staging F3-F4 fibrosis (AUC 0.863, 0.774, and 0.792, respectively), with LSM having the highest sensitivity (90%), and the highest NPV (94%), and NFS and FIB-4 the highest specificity (97% and 93%, respectively), and the highest PPV (73% and 79%, respectively). The paired combination of LSM or NFS with FIB-4 strongly reduced the likelihood of wrongly classified patients (ranging from 2.7% to 2.6%), at the price of a high uncertainty area (ranging from 54.1% to 58.2%), and of a low overall accuracy (ranging from 43% to 39.1%). The serial combination with the second test used in patients in the grey area of the first test and in those with high LSM values (>9.6 KPa) or low NFS or FIB-4 values (<-1.455 and <1.30, respectively) overall increased the diagnostic performance generating an accuracy ranging from 69.8% to 70.1%, an uncertainty area ranging from 18.9% to 20.4% and a rate of wrong classification ranging from 9.2% to 11.3%. CONCLUSION: The serial combination of LSM with FIB-4/NFS has a good diagnostic accuracy for the non-invasive diagnosis of severe fibrosis in NAFLD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Petta S, Wong VW, Cammà C, et al. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD. Aliment Pharmacol Ther. 2017. PMID: 28752524. doi:10.1111/apt.14219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。